Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage

Fig. 2

Efficacy of anti-PD-(L)1 therapy. Kaplan-Meier curves for A progression-free survival and B duration of response among the total patients who received anti-PD(L)1 therapy. C Progression-free survival was measured to compare active tuberculosis patients who received anti-tuberculosis therapy with patients diagnosed with latent or obsolete tuberculosis who received no anti-tuberculosis therapy. D Proportional representation of objective response rate in the above three groups

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us